AMERICAN ONCOLOGY NETWORK IN (AONC) Forecast, Price Target & Analyst Ratings
NASDAQ:AONC • US0287191029
2.14 USD
+0.44 (+25.88%)
At close: Jun 7, 2024
1.75 USD
-0.39 (-18.22%)
After Hours: 6/7/2024, 8:07:59 PM
View the latest analyst price targets, stock forecast, EPS estimates, revenue projections, revisions, full estimates, rating distribution and upgrades/downgrades for AMERICAN ONCOLOGY NETWORK IN (AONC).
Forecast Snapshot
Consensus Price Target
$0.00
-100.00% Downside
Next Earnings Forecast
Release DateN/A
ChartMill Buy Consensus
%
Weighted Analyst Rating Score
Price Target Details & History
Consensus Price Target and Range
Mean target
$0.00
Upside
-100.00%
From current price of $2.14 to mean target of $0.00, Based on analyst forecasts
Low
$0.00
Median
$0.00
High
$0.00
Price Target Revisions
1 Month
N/A
3 Months
N/A
Price Target Summary
Analyst Ratings & History
Current Analyst Ratings
Analyst Ratings History
Analyst Ratings Consensus
ChartMill Buy Consensus
%
Recent Upgrades & Downgrades
Next Earnings Forecast Details
Next Earnings Details
Release DateN/A
Next Earnings Revisions
Revenue (1 Month)
N/A
Revenue (3 Months)
N/A
EPS (1 Month)
N/A
EPS (3 Months)
N/A
Next Earnings Summary
Full Analyst Estimates
Yearly Earnings Per Share (EPS), Revenue, EBIT, EBITDA and Operating Margin Analyst Estimates
| 2021 | 2022 | 2023 | ||
|---|---|---|---|---|
| Revenue YoY % growth | 1.279B | |||
| EBITDA YoY % growth | N/A | N/A | -9.468M | |
| EBIT YoY % growth | -3.26M | -4.78M -46.63% | -17.918M -274.85% | |
| Operating Margin | N/A | N/A | -1.40% | |
| EPS YoY % growth | N/A | N/A | N/A |
All data in USD
Quarterly Earnings Per Share (EPS), Revenue, EBIT and EBITDA Analyst Estimates
| EPS Q2Q % growth |
|---|
| Revenue Q2Q % growth |
| EBITDA Q2Q % growth |
| EBIT Q2Q % growth |
All data in USD
Yearly Earnings Per Share (EPS) and Revenue Trends vs Historical Data
Long Term Forward Growth Forecast Summary
Long Term EPS Growth (CAGR)
EPS Next 3 Year
N/A
EPS Next 5 Year
N/A
Long Term Revenue Growth (CAGR)
Revenue Next 3 Year
N/A
Revenue Next 5 Year
N/A
Long Term EBIT Growth (CAGR)
EBIT Next 3 Year
N/A
EBIT Next 5 Year
N/A